Making Big Data and Advanced Analytics Work in Pharma Marketing

Date: June 27, 2012
Time: 11:00 a.m. PT / 2:00 p.m. ET
Click here to register for free!

Pharmaceutical marketers are grappling with both the exciting potential and daunting challenges associated with Big Data.  By focusing on the wealth of data captured from non-personal promotions and inbound and outbound prescriber interactions, marketers can apply advanced analytics to create a 360° view of their customer and deliver relevant, personalized offers.

Join MM&M, Janssen and FICO for a 30-minute webinar focused on sharing innovative data and analytic strategies in pharma marketing. The discussion will include:

  • Best practices in creating centralized customer data

  • How to use and analyze interaction data across the brand, franchise or company to derive deep insights into the tactics that drive the best results – plus, what it takes to make these analytics actionable

  • How to expand brand marketing programs globally, complying with regional privacy regulations

  • How to overcome barriers, such as declining access to prescribers and greater regulatory and legislative scrutiny

  • How to implement a customer-centric multi-channel approach

This webinar will include case studies illustrating real examples of how leading pharma marketers are making innovative use of centralized data and advanced analytics to deliver measurable improvements in their marketing campaigns.

Featured Speakers:
Debbie Kenworthy, Director of Business Analytics - Virology, Janssen
Todd Steffes, Vice President, Healthcare Practice FICO

Sponsored By:

You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.